http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
-
22nd Century Group (XXII) Secures $3.2 Million to Date in Warrant Exchange Transaction
-
22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
-
22nd Century (XXII) Appoints Larry Firestone as Chairman and CEO
-
22nd Century Group (XXII) to Sell Hemp/Cannabis Franchise
-
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
-
22nd Century Group (XXII) Prices 10M Share Offering at $0.525/sh
-
22nd Century Announces Pricing of $5.25 Million Public Offering
-
22nd Century Group (XXII) Announces Proposed Share Offering
-
22nd Century Announces Proposed Public Offering
-
22nd Century Group (XXII) Initiates Strategic Alternatives Process for Its Tobacco Assets
-
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
-
Presenting on the Emerging Growth Conference on September 6 and 7 Register Now
-
Presenting on the Emerging Growth Conference on August 9 & 10 Register Now
-
22nd Century Group (XXII) Names Interim CEO, Strengthens Balance Sheet and Implements $15 Million Cost Reduction Initiative
-
22nd Century Announces Executive Leadership Changes
-
22nd Century Group (XXII) Prices 779K Share Offering at $3.80/sh
-
22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market
-
22nd Century Group (XXII) Announces 1:15 Reverse Stock Split
-
22nd Century Announces 1-for-15 Reverse Stock Split
-
22nd Century Group (XXII) Announces 11.2M Share Offering at $0.47/sh
-
22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market
-
22nd Century Group (XXII) Reports Q1 Revenue of $22M, Net Loss of $18.2M; Guides FY23 Revenue of $105-$110M
-
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook
-
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
-
22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal
-
22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal
-
22nd Century Group (XXII) Launches New Private Label Brand with U.S. C-Store Chain
-
22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain
-
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
-
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
-
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
22nd Century Group (XXII) Announces $21M Debt Financing to Expand Working Capital for Growth Initiatives
-
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives
-
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference
-
22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023
-
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law
-
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law
-
Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less”
-
22nd Century Group (XXII) Acquires RX Pharmatech
-
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
-
22nd Century Group (XXII) Announces Filing of U.S. DMF for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
-
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
-
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown
-
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown
-
FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers
-
22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law
-
22nd Century Group Provides Update on Grass Valley Facility
-
22nd Century Group Provides Update on Incident at Grass Valley Facility
-
22nd Century Group's (XXII) GVB Biopharma Opens New Central Distribution Facility in The Netherlands

